Biological and analytical characterization of two extracts from Valeriana officinalis

Journal of Ethnopharmacology

Volumn 112, Issue 2, 2007, Pages 361-367

  Circosta, Clara ^a   De Pasquale, Rita ^a   Samperi, Stefania ^a   Pino, Annalisa ^a   Occhiuto, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Antibronchospastic; Anticoronaryspastic; Antihypertensive; Calcium channel blockade; Valeriana officinalis

Indexed keywords

ANTIGEN; HISTAMINE; NIFEDIPINE; VALERIAN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRONCHODILATING ACTIVITY; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; CHROMATOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORRELATION ANALYSIS; MALE; NONHUMAN; OLEACEAE; PRESSOR RESPONSE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; VALERIANA OFFICINALIS;

ALLERGENS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BRONCHIAL SPASM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; CORONARY VASOSPASM; GUINEA PIGS; HISTAMINE; HYPERTENSION; MALE; OLEACEAE; PARASYMPATHOLYTICS; PLANT EXTRACTS; PLANT ROOTS; SPECTROPHOTOMETRY, ULTRAVIOLET; ULTRASONICS; VALERIAN; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

CAVIA; OLEACEAE; VALERIANA; VALERIANA OFFICINALIS;

EID: 34248577482     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.03.021     Document Type: Article

References (25)

1. Blumenthal M. German Federal Institute for Drugs and Medical Devices. Commission E. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines (1998), American Botanical Council, Austin, TX p. 227
2. Bos R., Woerdenbag H.J., Hendriks H., Zwaving J.H., De Smet P.A.G.M., Tittel G., Wikström H.V., and Scheffer J.J.C. Analytical aspects of phytotherapeutic valerian preparations. Phytochemical Analysis 7 (1996) 143-151
3. Fuzzati N., Wolfender J.L., Hostettmann K., Msonthi J.D., Mavi S., and Molleyres L.P. Isolation of antifungal valepotriates from Valeriana capense and the search for valepotriates in crude Valerianaceae extracts. Phytochemical Analysis 7 (1996) 76-85
4. Goppel M., and Franz G. Stability control of valerian ground material and extracts: a new HPLC-method for the routine quantification of valerenic acids and lignans. Pharmazie 59 (2004) 446-452
5. Hazelhoff B., Malingré T.M., and Meijèr D.K. Antispasmodic effects of valeriana compounds: an in vivo and in vitro study on the guinea-pig ileum. Archivies Internationales des Pharmacodynamie 257 (1982) 274-287
6. Hoffman D. The Complete Illustrated Holistic Herbal (1996), Element Books Inc., Rockport, MA
7. Houghton P.J. The biological activity of valerian and related plants. Journal of Ethnopharmacology 22 (1988) 121-142
8. Klich R. Behavior disorders in childhood and their therapy. Die Medizinische Welt 26 (1975) 1251-1254
9. Konzert J., and Roessler D.M. Experimental method for investigating bronchial musculature. Archiv for Experimentelle Pathologie und Pharmakologie 195 (1940) 71-74
10. Malva J.O., Santos S., and Macero T. Neuroprotective properties of Valeriana officinalis extracts. Neurotoxicology Research 6 (2004) 131-140
11. Occhiuto F., Busà G., Ragusa S., and De Pasquale A. Comparative antiarrhythmic and anti-ischaemic activity of some flavones in the guinea pig and rat. Phytotherapy Research 5 (1991) 5-14
12. Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines (1999), William Morrow and Company Inc., New York
13. Popov S.S., and Handjieva N. Mass Spectrometry of valepotriates. Biomedical Mass Spectrometry 6 (1979) 124-128
14. Quattrone G., Occhiuto F., and Circosta C. Modello di broncospasmo indotto con diversi estratti allergenici nella cavia anestetizzata. Accademia Peloritana dei Pericolanti 77 (1990) 213-218
15. Rucker G., Tautges J., Sieck A., Wenzl H., and Graf E. Isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC. Arzneimittel-Forschung 28 (1978) 7-13
16. Schneider G., and Willems M. Erkenntnisse uber die Abbauprodukte der Valepotriate aus Kentranthus ruber (L.) DC. Archiv der Pharmazie 315 (1982) 691-697
17. Shohet D., Wills R.B., and Stuart D.L. Valepotriates and valerenic acids in commercial preparations of valerian available in Australia. Pharmazie 56 (2001) 860-863
18. Stahl E., and Schild W. Thin layer chromatography for determination of pharmacopeia drugs. Valerian root, valerian radix. Arzeneimittel-Forschung 19 (1969) 314-316
19. Stahl E., and Schild W. Über die Verbreitung der äquilibrierend wirkenden valepotriate in der familie der Valerianaceae. Phytochemistry 10 (1971) 147-153
20. Tavares-Murta B.M., Lefort J., Cunha F.Q., Ferriera S.H., and Vargaftig B.B. Interference of a neutrophil recrnitment inhibitory factor upon the accumulation of inflammatory cells and airway hyperreactivity in sensitised guinea-pig after intranasal antigen challenge. British Journal of Pharmacology 108 (1993) 538-543
21. Thies P.W. Die konstitution der Valepotriate-Mitteilung uber die Wirkstoffe des Baldrians. Tetrahedron 24 (1968) 313-347
22. Veith J., Schneider G., Lemmer B., and Willems M. Einfluss einiger Abbauprodukte von valepotriaten auf die Motilitat Licht-Dunkel Synchronisiester Mause. Planta Medica 52 (1986) 179-183
23. Wagner H., and Bladt S. Plant Drug Analysis (1996), Springer
24. Wagner H., and Jurcic K. On the spasmolytic activity of valeriana extracts. Planta Medica 37 (1979) 84-86
25. Wagner H., Jurcic K., and Schaette R. Comparative studies on the sedative action of Valeriana extracts, valepotriates and their degradation products. Planta Medica 39 (1980) 358-365